BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5706588)

  • 41. [Effects of isoxsuprine hydrochloride in threatened abortion].
    Cazzola D
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):382-96. PubMed ID: 5628977
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of vaginal wall cytologic smears to predict abortion in high-risk pregnancies.
    McLennan MT; McLennan CE
    Am J Obstet Gynecol; 1972 Dec; 114(7):857-60. PubMed ID: 4645123
    [No Abstract]   [Full Text] [Related]  

  • 43. [Laparoscopy in the differential diagnosis and treatment of acute appendicitis and acute gynecological diseases].
    Kulik IaP; Sedov VM; Strizheletskiĭ VV; Denisov IuO; Rutenburg GM; Guslev AB; Chuĭko IV; Soloveĭchik AS
    Vestn Khir Im I I Grek; 1996; 155(3):31-3. PubMed ID: 8966934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient parkinsonism: induced by progesterone or pregnancy?
    Demirkiran M; Aslan K; Bicakci S; Bozdemir H; Ozeren A
    Mov Disord; 2004 Nov; 19(11):1382-4. PubMed ID: 15389979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Threatened abortion, hormone therapy and malformed embryos.
    Oakley GP
    Teratology; 1979 Dec; 20(3):481-2. PubMed ID: 542900
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of anemia in obstetric and gynecologic patients with sustained-release and conventional iron preparations.
    Ziehm DJ; Likos J
    Obstet Gynecol; 1966 Sep; 28(3):430-4. PubMed ID: 5917754
    [No Abstract]   [Full Text] [Related]  

  • 47. [Action of orciprenaline administrated orally in threatened abortion].
    Uranga Imaz FA; Goñi JA; Selva A
    Obstet Ginecol Lat Am; 1973; 31(9-10):352-8. PubMed ID: 4806747
    [No Abstract]   [Full Text] [Related]  

  • 48. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
    Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
    J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dolo-Buscopan in gynecology].
    Gillessen H
    Med Klin; 1966 Sep; 61(36):1437-8. PubMed ID: 5996560
    [No Abstract]   [Full Text] [Related]  

  • 50. [Endoscopic appendectomy in gynecology].
    Ramsauer B; Raatz D; Dressler F; Zöckler R; Börner P
    Zentralbl Chir; 1998; 123 Suppl 4():58-60. PubMed ID: 9880876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Threatened abortion, hormone therapy, and malformed embryos: a comment.
    Sheehan DM; Holson JF
    Teratology; 1980 Dec; 22(3):351-2. PubMed ID: 7195081
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of therapeutic results of gestagen preparations in imminent abortion and preterm deliveries (author's transl)].
    Vierik J; Bruchác D; Handzo I; Ruttkayová A; Ponecová M
    Bratisl Lek Listy; 1980 Sep; 74(3):347-53. PubMed ID: 7417872
    [No Abstract]   [Full Text] [Related]  

  • 53. [No. 244. Elementary prescriptions for therapy of threatened abortion].
    Calzolari E
    Clin Ter; 1972 Jun; 61(6):577-82. PubMed ID: 4677564
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience with Diazepam in threatened abortion].
    Kawakami H; Yoshida S; Yoshida T; Makita M; Watanabe M
    Sanfujinka No Jissai; 1966 Mar; 15(3):270-7. PubMed ID: 6013899
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results of hormonal treatment in threatened and habitual abortion].
    Tarlantas D; Moschovakis K
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):563-4. PubMed ID: 5935246
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical use of Intacerin in threatened abortion].
    Watanabe K; Okano S; Iwai K; Suzumori K
    Sanfujinka No Jissai; 1968 Nov; 17(11):1018-22. PubMed ID: 5756208
    [No Abstract]   [Full Text] [Related]  

  • 57. [The use of isoxsuprine in the treatment of threatened abortion].
    Massobrio M; Sismondi P; Capra A; Campagnoli C
    Minerva Ginecol; 1969 Nov; 21(22):1570-6. PubMed ID: 5393543
    [No Abstract]   [Full Text] [Related]  

  • 58. [THE USE OF A PROGESTATIONAL SUBSTANCE IN CLINICAL PRACTICE].
    LAGOGR DO
    An Bras Ginecol; 1963 Jun; 55():329-36. PubMed ID: 14051286
    [No Abstract]   [Full Text] [Related]  

  • 59. [The pathogenesis of diabetes insipidus in pregnancy (description of a case)].
    Laghi A; Tomasillo MR
    Arch Ostet Ginecol; 1980; 85(4):297-305. PubMed ID: 7344669
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness of oxyprogesterone-capronate in threatened abortion].
    Pashchenko AG
    Vopr Okhr Materin Det; 1968 Apr; 13(4):59-63. PubMed ID: 5703209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.